Tocilizumab for Treatment of Children and Young Adults With Severe Acute COVID-19: Experience at a Quaternary-care Children's Hospital.
Pediatr Infect Dis J
; 42(2): 119-121, 2023 02 01.
Article
in En
| MEDLINE
| ID: mdl-36638396
ABSTRACT
We describe the clinical characteristics and outcomes of 16 children and young adults with severe acute COVID-19 who were treated with tocilizumab. Patients who were discharged by day 28 were more likely to be treated with tocilizumab earlier in their COVID-19 illness and had lower ferritin and interleukin-6 levels compared with those who were not discharged by day 28.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Observational_studies
Limits:
Adult
/
Child
/
Humans
Language:
En
Journal:
Pediatr Infect Dis J
Year:
2023
Document type:
Article